1. AB0007 Comparison of Peripheral Blood Gene Expression Profiles to Phenotype and Treatment Response in the Taser Early Rheumatoid Arthritis Study. (9th June 2015) Authors: Dale, J.; Nijjar, J.; McClure, J.; McBride, M.; Porter, D.; McInnes, I. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 893 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0160 Effects of TOFACITINIB (CP-690, 550) on lipid biomarkers in rat adjuvant-induced arthritis (AIA) model and in patients with active rheumatoid arthritis. (23rd January 2014) Authors: McInnes, I.; Kaplan, I.; Boy, M.; Riese, R.; Zuckerman, A.; Clark, J.; Kishore, N.; Brosnan, M.; Zwillich, S.; Bradley, J. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 646 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0747 Early and Sustained Modified PSARC Response in Psoriatic Arthritis Patients Treated with Ustekinumab: Results from PSUMMIT 1 and PSUMMIT 2. (10th June 2014) Authors: McInnes, I.; Ritchlin, C.; Rahman, P.; Puig, L.; Gottlieb, A.B.; Song, M.; Randazzo, B.; Li, S.; Wang, Y.; Mendelsohn, A.; Kavanaugh, A. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 1051 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0757 Achievement of A Combined Clinical and Radiographic Endpoint in Patients with Psoriatic Arthritis in the ADEPT Trial. (10th June 2014) Authors: Mease, P.; Karunaratne, P.M.; Kupper, H.; Hojnik, M.; Dorr, A.P.; McInnes, I. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 1054 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0927 Probability and impact of achieving low disease activity or remission in patients with psoriatic arthritis treated with apremilast: pooled analysis of the palace 1–3 phase 3 trials. (12th June 2018) Authors: McInnes, I.; Mease, P.J.; Behrens, F.; Orbai, A.-M.; Brunori, M.; Teng, L.; Guerette, B.; Smolen, J. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1588 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Acceptability of therapist training and delivery of a psychological informed gait rehabilitation intervention for people with early rheumatoid arthritis. (February 2022) Authors: Sekhon, M.; Godfrey, E.; Amirova, A.; Hendry, G.; Foster, N.; Hider, S.H.; van der Leeden, M.; Mason, H.; McConnachie, A. Alex; McInnes, I.; Patience, A.; Sackley, C.; Steultjens, M.; Williams, A.; Woodburn, J.; Bearne, L. Journal: Physiotherapy Issue: Volume 114(2022)Supplement 1 Page Start: e120 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. FRI0216 Long-Term Safety and Efficacy of Mavrilimumab, A Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor-Alpha Monoclonal Antibody, in Patients with Rheumatoid Arthritis. (15th July 2016) Authors: Burmester, G.; McInnes, I.; Kremer, J.; Miranda, P.; Vencovský, J.; Godwood, A.; Albulescu, M.; Close, D.; Weinblatt, M. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 510 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. FRI0420 Long term inhibition of IL-17a with secukinumab reduces spinal inflammation but has no influence on fatty lesions as assessed by magnetic resonance imaging in patients with ankylosing spondylitis. (23rd January 2014) Authors: Baraliakos, X.; Braun, J.; Laurent, D.; Baeten, D.; van der Heijde, D.; Sieper, J.; Emery, P.; McInnes, I.; van Laar, J.; Landewe, R.; Wordsworth, P.; Wollenhaupt, J.; Kellner, H.; Wright, A.; Vandenhende, F.; Radford, K.; Borah, B.; Hueber, W. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A516 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. FRI0451 Secukinumab Provides Rapid and Sustained Reductions in Dactylitis and Enthesitis in Patients with Psoriatic Arthritis: Analysis of Data from The Phase 3 Randomised, Multicentre, Double-Blind, Placebo-Controlled Future 2 Study. (15th July 2016) Authors: Kirkham, B.; Mease, P.; McInnes, I.; Bhosekar, V.; Mpofu, S.; Gandhi, K.; Gaillez, C. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 599 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. OP0001 Maintenance of Efficacy and Safety of Ustekinumab in Patients with Active Psoriatic Arthritis Despite Prior Conventional Nonbiologic and Anti-TNF Biologic Therapy: 1 Yr Results of the Psummit 2 Trial. (23rd January 2014) Authors: Ritchlin, C.; McInnes, I.; Kavanaugh, A.; Puig, L.; Rahman, P.; Li, S.; Shen, Y.; Doyle, M.; Mendelsohn, A.; Gottlieb, A. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A48 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗